These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1828690)

  • 1. Brachytherapy in head and neck cancer: selection criteria and results at the University of Florida. Part 1.
    Mendenhall WM; Parsons JT; Mendenhall NP; Million RR
    Oncology (Williston Park); 1991 Jan; 5(1):87-93. PubMed ID: 1828690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brachytherapy in head and neck cancer: selection criteria and results at the University of Florida.
    Mendenhall WM; Parsons JT; Mendenhall NP; Million RR
    Oncology (Williston Park); 1991 Feb; 5(2):44-54; discussion 59-60. PubMed ID: 1826208
    [No Abstract]   [Full Text] [Related]  

  • 3. [Brachytherapy of head and neck cancer].
    Takácsi Nagy Z; Kásler M
    Magy Onkol; 2008 Jun; 52(2):145-50. PubMed ID: 18640890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General principles of irradiation therapy as applied to head and neck cancer.
    Harwood AR; Keane TJ
    J Otolaryngol; 1982 Apr; 11(2):69-76. PubMed ID: 7077732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
    Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brachytherapy for head and neck cancers (nasopharynx excluded)].
    Lapeyre M; Bellière A; Hoffstetter S; Peiffert D
    Cancer Radiother; 2008 Nov; 12(6-7):515-21. PubMed ID: 18824384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas.
    Mazeron JJ; Ardiet JM; Haie-Méder C; Kovács G; Levendag P; Peiffert D; Polo A; Rovirosa A; Strnad V
    Radiother Oncol; 2009 May; 91(2):150-6. PubMed ID: 19329209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brachytherapy--own, preliminary experiences in the treatment of head and neck neoplasms with the use of pulsed brachytherapy].
    Zienkiewicz J; Ziemlewski A; Serkies K; Oleszkiewicz I; Nierzwicki B
    Wiad Lek; 2002; 55(9-10):569-74. PubMed ID: 12607412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
    Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
    Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy of neck metastases.
    Choo R; Grimard L; Esche B; Crook J; Genest P; Odell P
    J Otolaryngol; 1993 Feb; 22(1):54-7. PubMed ID: 7680385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
    Melzner WJ; Lotter M; Sauer R; Strnad V
    Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of curietherapy in the treatment of ENT tumors].
    Beauvois S
    Rev Med Brux; 1996 Apr; 17(2):86-90. PubMed ID: 8685553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent application methods of high dose-rate brachytherapy in head and neck tumors].
    Busch M
    Strahlenther Onkol; 1988 Oct; 164(10):610-8. PubMed ID: 3187893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vivo dosimetry in interstitial "low dose rate" afterloading therapy with Ir-192 seeds exemplified with head-neck tumors].
    Sadat Khonsari A; Grabenbauer G; Müller RG; Säbel M
    Strahlenther Onkol; 1991 Jul; 167(7):407-11. PubMed ID: 1858017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
    Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
    Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
    J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose rate sources in remote afterloading brachytherapy: implications for intracavitary and interstitial treatment of carcinoma.
    Syzek EJ; Bogardus CR
    J Okla State Med Assoc; 1990 Nov; 83(11):541-5. PubMed ID: 2273417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
    Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
    Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.